Randomized, Double-blind, Euglycemic Glucose Clamp Study of Four Formulations of SAR161271, in Single Doses in Healthy Subjects and Single Ascending Doses in Patients With Type 1 Diabetes Mellitus.

Trial Profile

Randomized, Double-blind, Euglycemic Glucose Clamp Study of Four Formulations of SAR161271, in Single Doses in Healthy Subjects and Single Ascending Doses in Patients With Type 1 Diabetes Mellitus.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Jul 2011

At a glance

  • Drugs Insulin glargine; SAR 161271
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Nov 2010 Actual end date changed from May 2010 to Nov 2010 as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Actual patient number (46) added as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top